Clinical Trials Logo

Neoplasms clinical trials

View clinical trials related to Neoplasms.

Filter by:

NCT ID: NCT01613066 Recruiting - Clinical trials for Advanced Haematological Malignancies

Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies

Start date: November 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Cord blood (CB) from an unrelated donor is increasingly used an alternative source of hematopoietic stem cells for adults with hematologic malignancies who lack an HLA-matched donor. However, the utilization of single-unit CB for transplantation of adult patients has been impeded by the low number of nucleated cells available from individual CB units. Direct intrabone CB injection (IBCBi) has been recently investigated as a solution to cell dose problem in adults, with the aims of minimizing non-specific loss of progenitors. We set up a phase I-II study to assess the safety and efficacy of CB transplantation by IBCBi in adult patients with advanced or high-risk hematological malignancies

NCT ID: NCT01593098 Recruiting - Adenoma Clinical Trials

A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)

AN
Start date: June 8, 2010
Phase:
Study type: Observational

To prospectively determine the prevalence of colorectal neoplasia in siblings of Hong Kong Chinese patients with advanced neoplasm compared with a sex and age-matched control population. To determine the molecular alteration profiles of colonic adenomas in siblings of patients with advanced neoplasm

NCT ID: NCT01579253 Recruiting - Glioblastoma Clinical Trials

Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients

Start date: April 2012
Phase: N/A
Study type: Observational

Patients with recurrent glioblastoma who are planned to receive a second course of radiation are to be included into this monocentric cohort trial. Due to multiple pre-treatments simultaneous combined positron emission tomography (PET) with O-(2-[18F]fluoroethyl)-l-tyrosine (FET) as well as magnetic resonance imaging (MRI) is used for treatment planning and follow-up imaging as it allows for a better distinction between treatment-related changes and viable tumor tissue.

NCT ID: NCT01577251 Recruiting - Clinical trials for Selected for Definitive Photodynamic Therapy, Proton, or Photon Radiation Therapy

The Radiation Oncology Registry and Biosample Repository

Start date: June 2008
Phase:
Study type: Observational

The goal of this study is two-fold: to establish a tissue banking respository (defined as blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor specimens), and to prospectively assess health related quality of life (QOL) over time in patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or photodynamic therapy (PDT)

NCT ID: NCT01567202 Recruiting - Neoplasms Clinical Trials

Study of DC Vaccination Against Glioblastoma

Start date: March 2012
Phase: Phase 2
Study type: Interventional

This is a Phase II study in a single center to determine the efficacy of autologous dendritic cells (DCs) loaded with autogeneic glioma stem-like cells (A2B5+) administered as a vaccination in adults with glioblastoma multiforme (primary or secondary).

NCT ID: NCT01564810 Recruiting - Clinical trials for Colorectal Neoplasms

Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer

Start date: September 2006
Phase: Phase 4
Study type: Interventional

In this study, the investigators assessed the effect of Cetuximab in combination with chemotherapy in the treatment of unresectable metastatic colorectal cancer.

NCT ID: NCT01549067 Recruiting - Colorectal Cancer Clinical Trials

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Sprit
Start date: September 2011
Phase: N/A
Study type: Observational

Collect the real clinical background of advanced colorectal cancer c of China.

NCT ID: NCT01542281 Recruiting - Colorectal Neoplasm Clinical Trials

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

Start date: January 2012
Phase: N/A
Study type: Interventional

1. To determine whether a combined nutritional support program and exercise-based prehabilitation is superior to nutritional support alone in increasing functional recovery and reducing post-operative morbidity after surgery for HPB malignancy. 2. To understand which measures of immediate surgical recovery are sensitive to prehabilitation interventions and predict change in later outcome measures.

NCT ID: NCT01535430 Recruiting - Primary Brain Tumor Clinical Trials

Assessment of Eloquent Function in Brain Tumor Patients

Start date: January 31, 2012
Phase:
Study type: Observational

Purpose of the study: AIM 1 Prospectively collect pre-operative (fMRI, DTI, MEG) and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the location of eloquent brain function. In addition, each modality will be compared with the other. AIM 2 Assess reorganization of eloquent brain function and plasticity in patients with intra-axial brain tumors. This will be accomplished by prospectively collecting post-operative mapping studies and neuropsychological tests to compare them to prior mapping studies as stated above.

NCT ID: NCT01533779 Recruiting - Clinical trials for Pediatric Solid Malignancies

Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity

Start date: February 2012
Phase: N/A
Study type: Observational

Examine neutrophil extracellular traps (NETs) formation, in relation to other neutrophil functions like chemotaxis, superoxide production, hydrogen peroxide production, and the presence of myeloperoxidase, in pediatric patients undergoing chemotherpy for solid and hematological malignancies. This data could shed new light on the mechanism responsible for the increased susceptibility to infection among these patients and aid in improving their prophylactic antimicrobial treatment. NETs formation against tumor cell lines and their ability to kill tumor cells will also be examined. The finding of NETs activity against tumor cells could have a major contribution to the investigators understanding of the function of the immune system against cancer.